Comment on 'Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis'

Jenabi Ensiyeh

首页> 外文期刊>International Journal of Cardiology >Comment on 'Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis'

【24h】

Comment on 'Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis'

机译：评论“非维生素K拮抗剂口腔抗凝血剂作为风格纤维素的甘氨酸安全有效，适用于心房颤动的心法素：系统审查和荟萃分析”

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Cardiology》 |2019年第2019期|共1页
作者
Jenabi Ensiyeh;
展开▼
作者单位

Hamadan Univ Med Sci Pediat Dev Disorders Res Ctr Hamadan Iran;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Comment on "Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis" [J] . Jenabi Ensiyeh International Journal of Cardiology . 2019,第期

机译：评论“非维生素K拮抗剂口腔抗凝血剂作为风格纤维素的甘氨酸安全有效，适用于心房颤动的心法素：系统审查和荟萃分析”
2. Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis [J] . Telles-Garcia Nelson, Dahal Khagendra, Kocherla Cyrus, International Journal of Cardiology . 2018,第期

机译：非维生素K拮抗剂口服抗凝血剂作为心甘训的抗心脏纤维素素的安全且有效：系统审查和荟萃分析
3. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis [J] . Kim In-Soo, Kim Hyun-Jung, Kim Tae-Hoon, Journal of cardiology . 2018,第1a2期

机译：与老年心房颤动患者的华法林相比，非维生素K拮抗剂口腔抗凝血剂具有更好的疗效和等同的安全性：系统评价和荟萃分析
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. The Bleeding Risk of Non-Vitamin K Antagonist Oral Anticoagulants in Cirrhotic Patients: A Systematic Review and Meta-Analysis [D] . Go, Rafael Francisco C. 2020

机译：肝硬化患者中非维生素K拮抗剂口腔抗凝剂的出血风险：系统审查和荟萃分析
6. Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience [O] . Naoki Shibata, Itsuro Morishima, Kenji Okumura, 2017

机译：非维生素K拮抗剂口服抗凝剂与华法林在心律失常中对心房纤颤的复律：单中心经验
7. Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials [O] . Giuseppe Gargiulo, Andreas Goette, Jan Tijssen, 2019

机译：经皮冠状动脉介入后心房颤动患者的双与抗血栓形成治疗的安全性和功效结果：非维生素K拮抗剂口腔抗凝剂随机临床试验的系统回顾和荟萃分析

Comment on 'Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis'

著录项

相似文献

相关主题

期刊订阅